Long-Acting Injectable ART Holds Up Through 48 Weeks in Young People Living With HIV in South Africa
Young people living with HIV in South Africa achieve high viral suppression rates on long-acting injectable antiretroviral therapy, and all who finished the study chose to continue treatment.
Against this backdrop, (Nasdaq:VBIO) ("Valion" or the "Company"), a clinical-stage biopharmaceutical company developing ...
All Penny Stocks (English) on MSN
Oral testosterone capsule wins Canadian approval, shares up
Testosterone replacement therapy has largely relied on delivery methods that come with practical tradeoffs. Injections ...
A new review synthesizes preclinical and clinical evidence showing that lipid nanoparticle biodistribution, mRNA persistence, ...
InvestorsHub on MSN
Lipocine Health Canada approval clears TLANDO for Canadian testosterone replacement market
Health Canada approved TLANDO for testosterone replacement therapy in adult men with hypogonadism, with Lipocine’s commercial ...
Randomized crossover trial will compare the pharmacokinetics and pharmacodynamics of intranasal epinephrine powder against ...
The Phase 3 SOLARIS trial showed symptom improvement and better personal and social functioning. WELTRUZA will be available in three strengths in coming weeks.
Pentobarbital injection, commonly referred to by the brand name Nembutal, is a short-acting barbiturate used in controlled ...
Dominican television presenter Charytín Goyco revealed that she was bitten by a black widow spider several days ago, ...
The lively discussions of October. And the challenging start to the day, with a remarkable conclusion: found it!
Phase 3b trial shows long-acting injectable therapy outperforms daily oral regimens for patients with detectable HIV-1 and adherence challenges.
A man allegedly broke into his neighbors' home, told officers they would die if they got close, then poured water on one and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results